Litcius/Paper detail

Mesoporous Silica Nanoparticle-Based Imaging Agents for Hepatocellular Carcinoma Detection

Xuqi Peng, Gan Lin, Yun Zeng, Zhao Lei, Gang Liu

2021Frontiers in Bioengineering and Biotechnology11 citationsDOIOpen Access PDF

Abstract

Hepatocellular carcinoma (HCC) is characterized by poor prognosis and high mortality. The treatment of HCC is closely related to the stage, and the early-stage of HCC patients usually accompanies a more long-term survival rate after clinical treatment. Hence, there are critical needs to develop effective imaging agents with superior diagnostic precision for HCC detection at an early stage. Recently, mesoporous silica nanoparticles (MSNs) based imaging agents have gained extensive attentions in HCC detection, which can serve as a multifunctional nanoplatform with controllable size and facile surface functionalization. This perspective summarizes recent advances in MSNs based imaging agents for HCC detection by the incorporation of several clinical imaging modalities. Multi-modal imaging system has been developed for higher spatial resolution and sensitivity. Even though some limitations and challenges need to be overcome, we envision the development of novel MSNs based imaging agents will offer great potential applications in clinical HCC detection.

Topics & Concepts

Hepatocellular carcinomaStage (stratigraphy)Mesoporous silicaClinical imagingNanotechnologyComputer scienceMaterials scienceMedicineCancer researchRadiologyMesoporous materialChemistryBiologyCatalysisBiochemistryPaleontologyNanoplatforms for cancer theranosticsCatalytic Processes in Materials ScienceAdvanced Nanomaterials in Catalysis
Mesoporous Silica Nanoparticle-Based Imaging Agents for Hepatocellular Carcinoma Detection | Litcius